Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line

PloS One
Sarai PongjantarasatianSuradej Hongeng

Abstract

Human mesenchymal stem cells (hMSCs) have the potential to differentiate into hepatocyte-like cells, indicating that these cells may be the new target cell of interest to produce biopharmaceuticals. Our group recently established a hMSC-derived immortalized hepatocyte-like cell line (imHC) that demonstrates several liver-specific phenotypes. However, the ability of imHC to produce coagulation factors has not been characterized. Here, we examined the potential for imHC as a source of coagulation protein production by investigating the ability of imHC to produce human factor VII (FVII) using a lentiviral transduction system. Our results showed that imHC secreted a low amount of FVII (~22 ng/mL) into culture supernatant. Moreover, FVII from the transduced imHC (0.11 ± 0.005 IU/mL) demonstrated a similar coagulant activity compared with FVII from transduced HEK293T cells (0.12 ± 0.004 IU/mL) as determined by chromogenic assay. We demonstrate for the first time, to the best of our knowledge, that imHC produced FVII, albeit at a low level, indicating the unique characteristic of hepatocytes. Our study suggests the possibility of using imHC for the production of coagulation proteins.

References

Nov 28, 1989·Biochemistry·A H PedersenL C Petersen
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·L V Rao, S I Rapaport
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·F S HagenK Kurachi
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrew I SuJohn B Hogenesch
Aug 16, 2002·British Journal of Haematology·David J Perry
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Françoise CarlottiRob C Hoeben
Apr 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Andrew I SuJohn B Hogenesch
Mar 23, 2005·Liver International : Official Journal of the International Association for the Study of the Liver·Reginald F ClaytonArvind H Patel
Dec 1, 2006·Preparative Biochemistry & Biotechnology·Tsuyoshi SakodaMitsumasa Ohyanagi
Jun 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Agnieszka BanasTakahiro Ochiya
Feb 5, 2008·The American Journal of Pathology·Paola DongiovanniSilvia Fargion
Mar 12, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Niresh HariparsadXiaoyan Chu
Jun 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Romy ZemelRan Tur-Kaspa
Jul 1, 2009·In Vitro Cellular & Developmental Biology. Animal·Yvonne ReidJudy Kantor
Dec 15, 2011·Methods in Molecular Biology·Adisak WongkajornsilpSuradej Hongeng
Nov 24, 2012·Nucleic Acids Research·Chunlei WuAndrew I Su
Jan 11, 2013·Physiological Reviews·Henri H VersteegPieter H Reitsma
Jan 17, 2013·Journal of Genetic Syndromes & Gene Therapy·Jianhua MaoWeidong Xiao
Dec 23, 2014·New Biotechnology·Lukas FliedlRegina Grillari-Voglauer
Mar 30, 2017·Journal of Clinical Medicine·Mariasanta NapolitanoGuglielmo Mariani
Jun 28, 2017·Protein Expression and Purification·Marcela Cristina Corrêa de FreitasDimas Tadeu Covas

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
PCR
ELISA
protein assay
X-ray

Software Mentioned

GraphPad
GraphPad Prism

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

© 2021 Meta ULC. All rights reserved